FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084341903> ?p ?o ?g. }

• W2084341903 endingPage "1956" @default.
• W2084341903 startingPage "1947" @default.
• W2084341903 abstract "COL4A3/COL4A4 mutations: From familial hematuria to autosomal-dominant or recessive Alport syndrome.BackgroundMutations of the type IV collagen COL4A5 gene cause X-linked Alport syndrome (ATS). Mutations of COL4A3 and COL4A4 have been reported both in autosomal-recessive and autosomal-dominant ATS, as well as in benign familial hematuria (BFH). In the latter conditions, however, clinical features are less defined, few mutations have been reported, and other genes and non-genetic factors may be involved.MethodsWe analyzed 36 ATS patients for COL4A3 and COL4A4 mutations by polymerase chain reaction–single strand conformational polymorphism (PCR-SSCP) and direct sequencing. Sporadic patients who had tested negative for COL4A5 mutations were included with typical cases of autosomal recessive ATS to secure a better definition of the phenotype spectrum.ResultsWe identified seven previously undescribed COL4A3 mutations: in two genetic compounds and three heterozygotes, and one in COL4A4. In agreement with the literature, some of the mutations of compound heterozygotes were associated with microhematuria in healthy heterozygous relatives. The mutations of heterozygous patients are likely dominant, since no change was identified in the second allele even by sequencing, and they are predicted to result in shortened or abnormal chains with a possible dominant-negative effect. In addition, both genes showed rare variants of unclear pathogenicity, and common polymorphisms that are shared in part with other populations.ConclusionsThis study extends the mutation spectrum of COL4A3 and COL4A4 genes, and suggests a possible relationship between production of abnormal COL IV chains and dominant expression of a continuous spectrum of phenotypes, from ATS to BFH. COL4A3/COL4A4 mutations: From familial hematuria to autosomal-dominant or recessive Alport syndrome. Mutations of the type IV collagen COL4A5 gene cause X-linked Alport syndrome (ATS). Mutations of COL4A3 and COL4A4 have been reported both in autosomal-recessive and autosomal-dominant ATS, as well as in benign familial hematuria (BFH). In the latter conditions, however, clinical features are less defined, few mutations have been reported, and other genes and non-genetic factors may be involved. We analyzed 36 ATS patients for COL4A3 and COL4A4 mutations by polymerase chain reaction–single strand conformational polymorphism (PCR-SSCP) and direct sequencing. Sporadic patients who had tested negative for COL4A5 mutations were included with typical cases of autosomal recessive ATS to secure a better definition of the phenotype spectrum. We identified seven previously undescribed COL4A3 mutations: in two genetic compounds and three heterozygotes, and one in COL4A4. In agreement with the literature, some of the mutations of compound heterozygotes were associated with microhematuria in healthy heterozygous relatives. The mutations of heterozygous patients are likely dominant, since no change was identified in the second allele even by sequencing, and they are predicted to result in shortened or abnormal chains with a possible dominant-negative effect. In addition, both genes showed rare variants of unclear pathogenicity, and common polymorphisms that are shared in part with other populations. This study extends the mutation spectrum of COL4A3 and COL4A4 genes, and suggests a possible relationship between production of abnormal COL IV chains and dominant expression of a continuous spectrum of phenotypes, from ATS to BFH." @default.
• W2084341903 created "2016-06-24" @default.
• W2084341903 creator A5003168053 @default.
• W2084341903 creator A5011657312 @default.
• W2084341903 creator A5012705049 @default.
• W2084341903 creator A5015196024 @default.
• W2084341903 creator A5031917877 @default.
• W2084341903 creator A5036049873 @default.
• W2084341903 creator A5036399965 @default.
• W2084341903 creator A5036752133 @default.
• W2084341903 creator A5043017507 @default.
• W2084341903 creator A5048154764 @default.
• W2084341903 creator A5048531929 @default.
• W2084341903 creator A5061988529 @default.
• W2084341903 creator A5062468995 @default.
• W2084341903 creator A5064306128 @default.
• W2084341903 creator A5064734961 @default.
• W2084341903 creator A5067345476 @default.
• W2084341903 creator A5070047711 @default.
• W2084341903 creator A5072848659 @default.
• W2084341903 creator A5074190551 @default.
• W2084341903 creator A5089081873 @default.
• W2084341903 date "2002-06-01" @default.
• W2084341903 modified "2023-10-01" @default.
• W2084341903 title "COL4A3/COL4A4 mutations: From familial hematuria to autosomal-dominant or recessive Alport syndrome" @default.
• W2084341903 cites W1534220125 @default.
• W2084341903 cites W1550732922 @default.
• W2084341903 cites W1604433450 @default.
• W2084341903 cites W164826677 @default.
• W2084341903 cites W1972022046 @default.
• W2084341903 cites W1976740378 @default.
• W2084341903 cites W1979044332 @default.
• W2084341903 cites W1988470091 @default.
• W2084341903 cites W1990054405 @default.
• W2084341903 cites W1998213310 @default.
• W2084341903 cites W2004814837 @default.
• W2084341903 cites W2005684733 @default.
• W2084341903 cites W2008948977 @default.
• W2084341903 cites W2010319731 @default.
• W2084341903 cites W2029863361 @default.
• W2084341903 cites W2037458235 @default.
• W2084341903 cites W2037655225 @default.
• W2084341903 cites W2048584442 @default.
• W2084341903 cites W2065712775 @default.
• W2084341903 cites W2081325069 @default.
• W2084341903 cites W2094608156 @default.
• W2084341903 cites W2106091175 @default.
• W2084341903 cites W2111016525 @default.
• W2084341903 cites W2128796050 @default.
• W2084341903 cites W2135094836 @default.
• W2084341903 cites W2154128234 @default.
• W2084341903 cites W2162467840 @default.
• W2084341903 cites W2169992994 @default.
• W2084341903 cites W2278732773 @default.
• W2084341903 cites W4211015908 @default.
• W2084341903 cites W4211157962 @default.
• W2084341903 doi "https://doi.org/10.1046/j.1523-1755.2002.00379.x" @default.
• W2084341903 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12028435" @default.
• W2084341903 hasPublicationYear "2002" @default.
• W2084341903 type Work @default.
• W2084341903 sameAs 2084341903 @default.
• W2084341903 citedByCount "196" @default.
• W2084341903 countsByYear W20843419032012 @default.
• W2084341903 countsByYear W20843419032013 @default.
• W2084341903 countsByYear W20843419032014 @default.
• W2084341903 countsByYear W20843419032015 @default.
• W2084341903 countsByYear W20843419032016 @default.
• W2084341903 countsByYear W20843419032017 @default.
• W2084341903 countsByYear W20843419032018 @default.
• W2084341903 countsByYear W20843419032019 @default.
• W2084341903 countsByYear W20843419032020 @default.
• W2084341903 countsByYear W20843419032021 @default.
• W2084341903 countsByYear W20843419032022 @default.
• W2084341903 countsByYear W20843419032023 @default.
• W2084341903 crossrefType "journal-article" @default.
• W2084341903 hasAuthorship W2084341903A5003168053 @default.
• W2084341903 hasAuthorship W2084341903A5011657312 @default.
• W2084341903 hasAuthorship W2084341903A5012705049 @default.
• W2084341903 hasAuthorship W2084341903A5015196024 @default.
• W2084341903 hasAuthorship W2084341903A5031917877 @default.
• W2084341903 hasAuthorship W2084341903A5036049873 @default.
• W2084341903 hasAuthorship W2084341903A5036399965 @default.
• W2084341903 hasAuthorship W2084341903A5036752133 @default.
• W2084341903 hasAuthorship W2084341903A5043017507 @default.
• W2084341903 hasAuthorship W2084341903A5048154764 @default.
• W2084341903 hasAuthorship W2084341903A5048531929 @default.
• W2084341903 hasAuthorship W2084341903A5061988529 @default.
• W2084341903 hasAuthorship W2084341903A5062468995 @default.
• W2084341903 hasAuthorship W2084341903A5064306128 @default.
• W2084341903 hasAuthorship W2084341903A5064734961 @default.
• W2084341903 hasAuthorship W2084341903A5067345476 @default.
• W2084341903 hasAuthorship W2084341903A5070047711 @default.
• W2084341903 hasAuthorship W2084341903A5072848659 @default.
• W2084341903 hasAuthorship W2084341903A5074190551 @default.
• W2084341903 hasAuthorship W2084341903A5089081873 @default.
• W2084341903 hasBestOaLocation W20843419031 @default.
• W2084341903 hasConcept C104317684 @default.
• W2084341903 hasConcept C12125453 @default.

• next